Literature DB >> 6830287

Prevalence and pattern of renal disease in eastern Libya.

A Y Elzouki, F Amin, O P Jaiswal.   

Abstract

A prospective study was conducted to identify the pattern and aetiology of kidney disease in children living in eastern Libya. A total of 343 patients was studied, representing 3% of annual admissions to the children's hospital. The major renal diseases were post-streptococcal glomerulonephritis (in 116), acute renal failure (in 93), and idiopathic nephrotic syndrome (in 65). Less common diseases were tubular transport defect (in 3) and end-stage renal disease (in 3). The mortality rate (excluding neonates) was below 1%. The pattern of kidney disease referred to this hospital in Libya was different from that reported in other parts of Africa.

Entities:  

Mesh:

Year:  1983        PMID: 6830287      PMCID: PMC1628108          DOI: 10.1136/adc.58.2.106

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  18 in total

1.  Renal failure following perinatal anoxia.

Authors:  I M Dauber; A N Krauss; P S Symchych; P A Auld
Journal:  J Pediatr       Date:  1976-05       Impact factor: 4.406

Review 2.  The renal regulation of acid-base balance and the disturbances noted in renal tubular acidosis.

Authors:  J Rodriguez-Soriano
Journal:  Pediatr Clin North Am       Date:  1971-05       Impact factor: 3.278

3.  Thrombocytopenia in patients with acute post-streptococcal glomerulonephritis.

Authors:  B S Kaplan; D Esseltine
Journal:  J Pediatr       Date:  1978-12       Impact factor: 4.406

4.  Epidemiology and prevention of kidney disease in Africa.

Authors:  R G Hendrickse
Journal:  Trans R Soc Trop Med Hyg       Date:  1980       Impact factor: 2.184

5.  The racial incidence of disease in hospital children in Durban.

Authors:  A G Wesley; J N Scragg; C J Rubidge; H L Wallace
Journal:  S Afr Med J       Date:  1967-04-01

6.  Clinical healing two to six years after poststreptococcal glomerulonephritis in Trinidad.

Authors:  E V Potter; S Abidh; A R Sharrett; E G Burt; M Svartman; J F Finklea; T Poon-King; D P Earle
Journal:  N Engl J Med       Date:  1978-04-06       Impact factor: 91.245

7.  High-dose corticosteroids: their use in treating idiopathic rapidly progressive glomerulonephritis.

Authors:  W M O'Neill; W B Etheridge; H A Bloomer
Journal:  Arch Intern Med       Date:  1979-05

8.  Abnormal membrane sodium transport in Liddle's syndrome.

Authors:  J D Gardner; A Lapey; P Simopoulos; E L Bravo
Journal:  J Clin Invest       Date:  1971-11       Impact factor: 14.808

9.  Acute renal failure in infants and children: outcome of 53 patients requiring hemodialysis treatment.

Authors:  E M Hodson; C M Kjellstrand; S M Mauer
Journal:  J Pediatr       Date:  1978-11       Impact factor: 4.406

10.  Nonoliguric acute renal failure.

Authors:  R J Anderson; S L Linas; A S Berns; W L Henrich; T R Miller; P A Gabow; R W Schrier
Journal:  N Engl J Med       Date:  1977-05-19       Impact factor: 91.245

View more
  4 in total

1.  Primary nephrotic syndrome in Arab children.

Authors:  A Y Elzouki; F Amin; O P Jaiswal
Journal:  Arch Dis Child       Date:  1984-03       Impact factor: 3.791

2.  The Burden and Outcome of Pediatric Renal Admissions at the Federal Teaching Hospital Abakaliki: A 3-year Review (2011-2013).

Authors:  V U Muoneke; A F Una; C B Eke; O U Anyanwu
Journal:  Ann Med Health Sci Res       Date:  2016 Jul-Aug

Review 3.  Prospects of genetic testing for steroid-resistant nephrotic syndrome in Nigerian children: a narrative review of challenges and opportunities.

Authors:  Emmanuel Ademola Anigilaje; Ayodotun Olutola
Journal:  Int J Nephrol Renovasc Dis       Date:  2019-05-08

4.  Epidemiology and outcomes of children with renal failure in the pediatric ward of a tertiary hospital in Cameroon.

Authors:  Marie Patrice Halle; Carine Tsou Lapsap; Esther Barla; Hermine Fouda; Hilaire Djantio; Beatrice Kaptue Moudze; Christophe Adjahoung Akazong; Eugene Belley Priso
Journal:  BMC Pediatr       Date:  2017-12-06       Impact factor: 2.125

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.